From the publisher feed
Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoring Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal. GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar le
Read the original at The Guardian ↗Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.
A useful next step
- Read the short publisher description here.
- Open the full report directly at the publisher.
- Compare this topic with other sources when useful.